[1] Mosca F, Colnaghi M,Fumagalli M.BPD: old and new problems[J].J Matern Fetal Neonatal Med,2011,24(Suppl 1):80-82.
[2] Taha D, Kirkby S, Nawab U, et al.Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants[J].J Matern Fetal Neonatal Med,2014,27(16):1698-1702.
[3] Michael Z, Spyropoulos F, Ghanta S, et al.Bronchopulmonary dysplasia: an update of current pharmacologic therapies and new approaches [J].Clin Med Insights: Pediatr,2018,12:1-12.
[4] Collins JJP, Tibboel D, de Kleer IM, et al.The future of bronchopulmonary dysplasia: emerging pathophysiological concepts and potential new avenues of treatment [J].Front Med,2017,4:61. [5] Hasan SU, Potenziano J, Konduri GG, et al.Effect of inhaled nitric oxide on survival without bronchopulmonary dysplasia in preterm infants: a randomized clinical trial [J].JAMA Pediatr,2017,171(11): 1081-1089.
[6] Ee MT, Thébaud B.The therapeutic potential of stem cells for bronchopulmonary dysplasia: “it′s about time” or “not so fast” ?[J].Curr Pediatr Rev,2018,14(4): 227-238.
[7] da SilvaGoncalves E, Mezzacappa-Filho F, Severino SD, et al.Association between clinical variables related to asthma in school children born with very low birth weight with and without bronchopulmonary dysplasia [J].Rev Paul Pediatr,2016,34(3):271-280.
[8] Davidson LM,Berkelhamer SK.Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes [J].J Clin Med,2017,6:4.
[9] Principi N, Di Pietro GM, Esposito S.Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies [J].J Transl Med,2018,16: 36.
[10] Silva LV, de Araujo LB, de Oliveira Azevedo VMG.Assessment of the neuropsychomotor development in the first year of life of premature infants with and without bronchopulmonary dysplasia [J].Rev Bras Ter Intensiva,2018,30(2):174-180.
[11] Maitre NL, Ballard RA, Ellenberg JH,et al.Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach[J].J Perinatol,2015,35:313-321.
[12] Poindexter BB,Feng R, Schmidt B, et al.Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program[J].Ann Am Thorac Soc,2015,12(12):1822-1830.
[13] Pomar EG, Concina VA, Samide A,et al.Bronchopulmonary dysplasia: comparison between the two most used diagnostic criteria [J].Front Pediatr,2018,6: 397.
[14] 刘敬,黄俊谨,陈颖,等.肺脏超声对早产儿长期氧依赖肺部原因的鉴别价值[J].中国小儿急救医学,2014,21(12):786-789.
[15] Liu J, Chen SW, Liu F, et al.BPD, not BPD, or iatrogenic BPD: findings of lung ultrasound examinations [J].Medicine,2014,93(23):e133.
[16] Liu J, Cao HY, Wang XL, et al.The significance and the necessity of routinely performing lung ultrasound in the neonatal intensive care units [J].J Matern Fetal Neonatal Med,2016,29(24): 4025-4030.
[17] 刘敬.新生儿监护病房内开展肺脏超声的可行性与必要性[J].中华围产医学杂志,2013,6(10):582-584.
[18] 刘敬.NICU面临的伦理问题[J].中国儿童保健杂志,2013,21(2):152-154.
[19] Morrow LA, Wagner BD, Ingram DA, et al.Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants[J].Am J Respir Crit Care Med,2017,196(3):364-374.
[20] Fanos V, Pintus MC, Lussu M, et al.Urinary metabolomics of bronchopulmonary dysplasia(BPD): preliminary data at birth suggest it is a congenital disease [J].J Matern Fetal Neonatal Med,2014,27(Suppl 2):39-45.